Aside from a brutal PC environment, Marvell continues to be hurt by weakness in its mobile and wireless end-markets, which resulted in a 42% and 24% year-over-year revenue drop, respectively. I'm just speculating here, but in my attempts to connect the dots, I can't rule out that Marvell could have been stung by what was a much swifter decline in sales of BlackBerry's (BBRY) older model devices.
Although there is cause for optimism, given the recent launches of BlackBerry's Z10 and Q10 phones, early sales results are not overwhelming. That's not to say that Marvell can't still gain from just modest BB10 growth. But so far, the Street has not been overly impressed with BlackBerry sales. Accordingly, analysts have taken a wait-and-see attitude with BlackBerry, which reports earnings next week.
It wouldn't surprise me to see shares of Marvell inch higher if BlackBerry sales exceed expectations. But this is a risky proposition. Given the gains that Marvell has already posted this year, it just doesn't seem prudent. The best might have already arrived. Before you disagree, I think I did pretty well by timing the bottom when I did last December. This was when the Street was prepared to send Marvell to the glue factory.
Marvell's management deserves plenty of credit for having steered the company from the brink of collapse into a sea of growing margins. But truth be told, even though the company is no longer an ugly duckling, there's still too much that needs to go right for this stock to advance further.Accordingly, I would advise moving on names like Intel (INTC - Get Report) and Nvidia (NVDA), which present less risk and more upside potential. It doesn't have to be a case of feast or famine. At the time of publication, the author held no position in any of the stocks mentioned. Follow @saintssense This article was written by an independent contributor, separate from TheStreet's regular news coverage.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts